Atropine has been the prototype of an anticholinergic drug throughout many centuries. Owing to the side effects of atropine on the central nervous system, many investigators have searched for other anticholinergic drugs. As a result from these investigations, tertiary amines and quaternary ammonium compounds were developed with anticholinergic activity after parenteral administration. From the literature review on pharmacokinetics and pharmacodynamics of the anticholinergic drugs it can be concluded that the results after oral administration of quaternary ammonium compounds are conflicting.
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The aim of our study was to examine the dose -plasma level -effect-intrinsic potency relation for a number of quarternary anticholinergic compounds (butylscopolamine, methylatropine and propantheline) and for a tertiary drug (cetiedil), claimed to have a broader pharmacological profile. The question to be answered was: do these drugs, in so far as these parameters are concerned, differ from atropine and/or from each other, and, if so, what may be the clinical implications?
The structure-activity relationship of the anticholinergic drugs is reviewed in chapter I. A review of the acute toxicity and the pharmacokinetic data of butylscopolamine, methylatropine, propantheline and cetiedil and the reference drug atropine is given in chapter z part A; a review of the pharmacodynamic data of these anticholinergics is given in chapter 2 part B. The materials, methods and subjects used for the investigations are presented in chapter 3. In chapter 4 the pharmacokinetics (results after intravenous, oral and rectal administration in man) are presented; chapter 5 deals with the pharmacodynamic activity (the influence on the saliva secretion in man) and chapter 6 is devoted to the activity in vitro, i.e. the effects on isolated organs.
Even with sensitive detection methods like spectrophotometry, spectrofluorimetry and gas-liquid chromatography the expectedly very low plasma levels of the parent quaternary ammonium compounds and their metabolites after oral and rectal drug administration cannot be determined. Therefore it was decided to follow a very sensitive radiochemical method, by using 14C-labelled compounds.
It can be concluded that the search for a better understanding of the relationship yielded varying, partly unexpected, but nevertheless interesting information. Methylatropine seemed to do what one might expect: a rather poor absorption, some metabolism and effects -probably due to the parent drug -that are in accordance with the intrinsic potency of the compound. Propantheline was subjected to considerable metabolic degradation, especially after oral administration. However, it is not the metabolites, as one could have speculated, which are responsible for the effects, but the small proportion of unchanged drug that will reach the general circulation. A pharmacody-namic behaviour that fits well with the very high intrinsic potency of the drug. The tertiary amine cetiedil will certainly not reach the general circulation in an unchanged form after either oral or rectal administration. Still, an obvious anticholinergic effect is observed; one can conclude that, in contrast with propantheline, an active metabolite must be involved here. Finally, butylscopolamine gives hardly any effect after enteral administration. Whether this is true for the gut is not clear: the large volume of distribution (857 1) is compatible with local accumulation especially in the intestines. And as far as the effect on other smooth musculature, i.e. the ureter, is concerned: the effect does not seem to depend on the anticholinergic potency at all, but rather, on a non-specific, so-called musculotropic mechanism. This is not shared by atropine and, in clinical practice, it will probably be of no importance for methylatropine and propantheline.
Hence, though cholinergic transmission is a relatively well understood mechanism and the antagonism by anticholinergics as well, the work presented in this thesis indicates that in fact a great discrepancy between the simple mechanism and clinical practice may be found that is due to a great variability in the doseplasma level--effect-intrinsic potency relationships of the drugs that are in use. During biotransformation of xenobiotics (foreign compounds, such as drugs, pesticides, food additives, industrial chemicals, etc.), harmless compounds can be transformed into reactive intermediates (bioactivation). These intermediates can interact with cellular macromolecules (nucleic acids, proteins, etc.), leading to toxic effects like carcinogenesis, mutagenesis or tissue necrosis. The involvement of reactive intermediates in such processes can be detected via their capacity to induce mutations in suitable animals models. In this respect the fruitfly Drosophila melanogaster, which is the classical object of mutation research, offers advantages.
Xenobiotic-metabolizing enzymes in the fruitfly Drosophila melanogaster and the albino rat, with emphasis on glutathione S-transferase
The thesis describes studies concerning the capacity of Drosophila to metabolize xenobiotics, for which purpose some important xenobiotic-metabolizing enzymes were investigated.
In subcellular fractions of Drosophila melanogaster the presence of cytochrome P45o and bs was demonstrated, together with aryl hydrocarbon hydroxylase. Also glutathione S-transferase, epoxide hydratase and phosphotransferase were shown to be present. The properties of these enzymes were compared with those of similar enzymes from rat liver. It is concluded that a better understanding of the bioactivating and -inactivating processes occurring in Drosophila melanogaster will contribute to further improve the interpretation of experimental results using Drosophila in genetic toxicology testing.
Reactive intermediates originating in bioactivation can in turn be inactivated (detoxified) by the organism; in this respect the glutathione
